Aveanna Q3 revenue $509M (+6.5% YoY); Adj EBITDA $47.8M (+32.2%); raises FY24 guidance

Aveanna Healthcare Holdings, Inc.

2024-Q3 EPS reported -$0.21 revenue$1,504,634,000

Q3 revenue $509.0M, up 6.5% YoY; gross margin improved to 31.4% from 30.8%.
Net loss narrowed to $42.8M from $102.4M; adjusted net income $4.6M (adjusted EPS $0.02) vs loss of $0.03.
Adjusted EBITDA $47.8M, up 32.2% vs prior year.
FY2024 revenue guidance raised to ~$2.0B; Adjusted EBITDA guidance raised to >$168M.
Private Duty Services revenue increased $24.8M, Medical Solutions +$5.1M, Home Health & Hospice +$1.2M.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.